CSIMarket
 


Myriad Genetics Inc  (MYGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

MYGN's EPS Net Growth by Quarter and Year

Myriad Genetics Inc's EPS Net results by quarter and year




MYGN EPS Net (in $) FY 2019 FY 2018 FY 2017 FY 2016
IV Quarter June 1.92 0.09 0.06 0.44
III Quarter March 0.09 0.16 0.09 0.41
II Quarter December 0.03 0.45 -0.02 0.37
I Quarter September -0.01 1.15 0.48 0.26
FY   2.03 1.85 0.61 1.48



MYGN EPS Net forth quarter 2019 Y/Y Growth Comment
Myriad Genetics Inc achieved in the forth quarter, above Company average EPS Net surge of 2036.62% year on year, to $ 1.92 .

According to the results reported in the forth quarter, Myriad Genetics Inc achieved the best EPS Net growth in Biotechnology & Drugs industry. While Myriad Genetics Inc' s EPS Net doubling of 2036.62% ranks overall at the positon no. 10 in the forth quarter.




MYGN EPS Net ( Y/Y Growth %) 2019
2018 2017 2016
IV Quarter June 2036.62 % 50 % -86.36 % 51.72 %
III Quarter March -43.75 % 77.78 % -78.05 % 28.13 %
II Quarter December -93.33 % - - 76.19 %
I Quarter September - 139.58 % 84.62 % -39.53 %
FY   9.89 % 203.28 % -58.78 % -

Financial Statements
Myriad Genetics Inc's forth quarter 2019 EPS Net $ 1.92 MYGN's Income Statement
Myriad Genetics Inc's forth quarter 2018 EPS Net $ 0.09 Quarterly MYGN's Income Statement
New: More MYGN's historic EPS Net Growth >>


MYGN EPS Net (Quarter on Quarter Growth %)

2019
2018 2017 2016
IV Quarter June 2036.62 % -43.75 % -33.33 % 7.32 %
III Quarter March 200 % -64.44 % - 10.81 %
II Quarter December - -60.87 % - 42.31 %
I Quarter September - 1816.67 % 9.09 % -10.34 %
FY (Year on Year)   9.89 % 203.28 % -58.78 % -




EPS Net forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #1
Overall #10

EPS Net Y/Y Growth Statistics
High Average Low
2068.5 % 122.4 % -93.33 %
(Jun 30 2019)   (Dec 31 2018)
EPS Net forth quarter 2019 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #1
Overall #10
EPS Net Y/Y Growth Statistics
High Average Low
2068.5 % 122.4 % -93.33 %
(Jun 30 2019)   (Dec 31 2018)

EPS Net by Quarter for the Fiscal Years 2016, 2017, 2018, 2019

Myriad Genetics Inc's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
2036.62 % 87.73 % -100 %
(Jun 30 2019)  


MYGN's IV. Quarter Q/Q EPS Net Comment
Myriad Genetics Inc achieved in the IV. Quarter 2019 above company average sequential EPS Net doubling of 2036.62%, to $ 1.92 , from $0.09 in the third quarter.
MYGN is going from strength to strength, not just reporting above regular growth, but also increasing pace.

Within Biotechnology & Drugs industry Myriad Genetics Inc achieved highest sequential EPS Net growth. While Myriad Genetics Inc's EPS Net growth quarter on quarter, overall rank is 14.


EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #4
Overall #14
EPS Net Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #1
Healthcare Sector #4
Overall #14
EPS Net Q/Q Growth Statistics
High Average Low
2036.62 % 87.73 % -100 %
(Jun 30 2019)  


MYGN's IV. Quarter Q/Q EPS Net Comment
Myriad Genetics Inc achieved in the IV. Quarter 2019 above company average sequential EPS Net doubling of 2036.62%, to $ 1.92 , from $0.09 in the third quarter.
MYGN is undergoing a remarkable growth, not only claiming above average increase, and also increasing speed, Amelia Scott, Healthcare sector advisor mentioned.

Within Biotechnology & Drugs industry Myriad Genetics Inc achieved highest sequential EPS Net growth. While Myriad Genetics Inc's EPS Net growth quarter on quarter, overall rank is 14.


Myriad Genetics Inc's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Jun 30 2019)
12 Months Ending
(Mar 31 2019)
12 Months Ending
(Dec 31 2018)
12 Months Ending
(Sep 30 2018)
12 Months Ending
(Jun 30 2018)
Cumulative EPS Net 12 Months Ending $ 2.03 $ 0.20 $ 0.27 $ 0.69 $ 1.85
Y / Y EPS Net Growth (TTM) 9.97 % -89.08 % -84.65 % -46.2 % 201.83 %
Year on Year EPS Net Growth Overall Ranking # 952 # 1781 # 2035 # 1837 # 186
Seqeuential EPS Net Change (TTM) 923.25 % -26.05 % -60.99 % -62.75 % 1.58 %
Seq. EPS Net Growth (TTM) Overall Ranking # 6 # 1832 # 2125 # 2225 # 1502




Cumulative EPS Net growth Comment
Although Myriad Genetics Inc's Annual EPS Net growth year on year were below company's average 23.17% , EPS Net announced in the Jun 30 2019 period, show improvement in EPS Net trend, to cumulative trailing twelve month growth of 9.97% year on year, from -89.08% in Mar 31 2019.

In the Healthcare sector 60 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 952, from total ranking in previous quarter at 1781.

EPS Net TTM Q/Q Growth Statistics
High Average Low
923.25 %
44.24 %
-62.75 %
(Jun 30 2019)  

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 5
Healthcare Sector # 61
Overall # 950

EPS Net TTM Y/Y Growth Statistics
High Average Low
419.48 %
23.17 %
-89.08 %
(March 31, 2016)  


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 2
S&P 500 # 6
Cumulative EPS Net growth Comment
Although Myriad Genetics Inc's Annual EPS Net growth year on year were below company's average 23.17% , EPS Net announced in the Jun 30 2019 period, show improvement in EPS Net trend, to cumulative trailing twelve month growth of 9.97% year on year, from -89.08% in Mar 31 2019.

In the Healthcare sector 60 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 952, from total ranking in previous quarter at 1781.

EPS Net TTM Q/Q Growth Statistics
High Average Low
923.25 %
44.24 %
-62.75 %
(Jun 30 2019)  


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry # 5
Healthcare Sector # 61
Overall # 950

EPS Net TTM Y/Y Growth Statistics
High Average Low
419.48 %
23.17 %
-89.08 %
(March 31, 2016)  


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 1
Sector # 2
S&P 500 # 6




Other EPS Net Growth
Biotechnology & Drugs Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
MYGN's EPS Net Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for MYGN's Competitors
EPS Net Growth for Myriad Genetics Inc's Suppliers
EPS Net Growth for MYGN's Customers

You may also want to know
MYGN's Annual Growth Rates MYGN's Profitability Ratios MYGN's Asset Turnover Ratio MYGN's Dividend Growth
MYGN's Roe MYGN's Valuation Ratios MYGN's Financial Strength Ratios MYGN's Dividend Payout Ratio
MYGN's Roa MYGN's Inventory Turnover Ratio MYGN's Growth Rates MYGN's Dividend Comparisons



Companies with similar EPS Net doubling for the quarter ending Jun 30 2019 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Jun 30 2019
Myriad Genetics Inc  2,068.50 %$ 2,068.503 
Fitlife Brands, Inc.  2,050.00 %$ 2,050.000 


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CIRT's Profile

Stock Price

CIRT's Financials

Business Description

Fundamentals

Charts & Quotes

CIRT's News

Suppliers

CIRT's Competitors

Customers & Markets

Economic Indicators

CIRT's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071